Back to DE D. E. Shaw & Co., Inc.
MCRB
Showing 0 of 19 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Seres Therapeutics, Inc.
No. D. E. Shaw exited its MCRB (Seres Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 486,353 shares worth $376,486. D. E. Shaw already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.